FDA Inspection
Fayetteville VA Medical CenterFayetteville VA Medical Center – FDA Inspection, Jun 15, 2026
Record Details
This FDA Inspection record concerns Fayetteville VA Medical Center, with an inspection on June 15, 2026, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · c18aca30-bd71-419b-a820-bc274b80be28
Inspection Facts
- Inspection number
- 1322070
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- FDCA 501(a)(2)(A)Beta-lactam, hazardous, highly potent drugs, prevention of cross-contamination
- FDCA 501(a)(2)(A)Failure to clean and disinfect/sterilize equipment, ISO 5 area
- FDCA 501(a)(2)(A)Microbial contamination was present, ISO 5/areas adjacent
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fayetteville VA Medical Center
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 24, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 9, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 14, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 31, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Fayetteville VA Medical Center
- FDA Inspection 1247783 - 2024-08-27
- FDA Inspection 1050600 - 2018-04-24
- FDA Inspection 959737 - 2016-02-09
- FDA Inspection 862688 - 2014-01-14
- FDA Inspection 767084 - 2012-01-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.